Fixes Book Closure for A G M
Mangalam Drugs & Organics Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2012 to September 27, 2012 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company. Financial Results & Limited Review for June 30, 2012
Mangalam Drugs & Organics Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2012. Outcome of Board Meeting
Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 23, 2012, has not recommended payment of dividend for the financial year 2011-2012. Auditied Financial Results & Auditors Report for March 31, 2012
Mangalam Drugs & Organics Ltd has informed BSE about the Audited Financial Results & a copy of the Auditors Report for the period ended March 31, 2012. Board to consider Dividend
Mangalam Drugs & Organics Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 23, 2012, inter alia to consider and approve the Audited Financial Results for the year ended March 31, 2012 and to recommend dividend, if any. Limited Review for March 31, 2012
Mangalam Drugs & Organics Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended March 31, 2012. Financial Results for March 31, 2012
Mangalam Drugs & Organics Ltd has informed BSE about the Financial Results for the period ended March 31, 2012. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Govardhan Dhoot has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE. Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Govardhan M Dhoot has submitted the disclosure under Regulation 13(4), 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: